Pacira BioSciences, Inc. (FRA:82P)

Market Cap	874.48M
Revenue (ttm)	610.92M
Net Income (ttm)	18.27M
Shares Out	n/a
EPS (ttm)	0.40
PE Ratio	47.86
Forward PE	6.52
Dividend	n/a
Ex-Dividend Date	n/a

Volume	n/a
Average Volume	19
Open	19.60
Previous Close	20.20
Day's Range	19.60 - 20.00
52-Week Range	15.70 - 26.20
Beta	n/a
RSI	52.63
Earnings Date	Feb 26, 2026

About Pacira BioSciences

Pacira BioSciences, Inc. engages in the development, manufacture, marketing, distribution, and sale of non-opioid pain management and regenerative health solutions to healthcare practitioners in the United States. The company offers EXPAREL, a bupivacaine liposome injectable suspension for postsurgical pain management; ZILRETTA, a triamcinolone acetonide extended-release injectable suspension indicated for the management of osteoarthritis and knee pain; and iovera system, a non-opioid handheld cryoanalgesia device used to deliver controlled dos...

• Industry: Pharmaceutical Preparations
• Founded: 2006
• Employees: 790
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: 82P

Financial Performance

Financial numbers in USD